“…To evaluate the genetic heterogeneity of the disease, we analyzed mutations in the PAH gene and the associated haplotypes, and correlated the genotype with the phenotype based on pretreatment phenylalanine levels. Pérez et al [1996] conducted a study on 79 patients with PKU from São Paulo, but their approach to the detection of mutations was very limited since the study was directed only to the search of some mutations (IVS10nt-11G→a, I65T, V388M, R408W, and IVS12nt1G→A) with a high incidence in Europe. In the present study, we used a methodology for efficient mutational screening, i.e., DGGE and broad-range DGGE, which are widely employed for the study of mutations in various populations [Guldberg et al, 1993a;Guldberg et al, 1993b;Hennermann et al, 2000], as well as SSCP for the analysis of some exons of the PAH gene [Labrune et al, 1991;Zschocke et al, 1995;Van der SijsBos et al, 1996].…”